fremanezumab
Treatment for Cluster Headache
Fremanezumab is a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), which plays a critical role in pain signaling and vasodilation associated with cluster headaches. By binding and neutralizing CGRP, fremanezumab reduces neurogenic inflammation and pain transmission, thereby potentially decreasing the frequency and severity of cluster headache episodes.
1497
REPORTED SIDE EFFECTS